Windlas Biotech Ltd - 543329 - Update on board meeting
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 ,inter alia, to consider and approve Windlas Biotech Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider Buyback Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2022
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 ,inter alia, to consider and approve Un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2022 Windlas Biotech Ltd - 543329 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ananta Narayan PandaDesignation :- Company Secretary and Compliance Officer Windlas Biotech Ltd - 543329 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2022 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Windlas Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Windlas Biotech Ltd - 543329 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 21st Annual General Meeting (AGM) held on September 19, 2022 Windlas Biotech Ltd - 543329 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 21st Annual General Meeting of the Company held on September 19, 2022, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015